2016
DOI: 10.1016/j.ijpharm.2015.12.057
|View full text |Cite
|
Sign up to set email alerts
|

Molecularly designed lipid microdomains for solid dispersions using a polymer/inorganic carrier matrix produced by hot-melt extrusion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 20 publications
(8 citation statements)
references
References 21 publications
0
8
0
Order By: Relevance
“…1). Adler et al prepared an amorphous solid dispersion composed of a mixture of b-carotene, polymer, lipid, and silica by the hot-melt extrusion method and studied its physicochemical properties (Adler et al 2016). They reported that the structure of this solid dispersion was influenced by H-bonding and ion-dipole interactions between lipid and silica.…”
Section: Discussionmentioning
confidence: 99%
“…1). Adler et al prepared an amorphous solid dispersion composed of a mixture of b-carotene, polymer, lipid, and silica by the hot-melt extrusion method and studied its physicochemical properties (Adler et al 2016). They reported that the structure of this solid dispersion was influenced by H-bonding and ion-dipole interactions between lipid and silica.…”
Section: Discussionmentioning
confidence: 99%
“…relatively lower temperature and mechanical activity) compared to temperature-based and mechanical-based methods make them more flexible in terms of selecting the best compound and excipient, as long as both components are miscible and soluble in the solvent system used. However, more stringent criteria are required for temperature-based methods, including criteria for the T g and the T m of both the compound and the excipient, the viscosity of the excipient, the miscibility of the components, the extrudability of the mixture, and the potential degradation of the compound on exposure to high temperature during the process (74,76,103,109,129,138,150,155,175). These could limit the applicability and use of temperature-based methods in the preparation and study of amorphous formulations.
Fig.
…”
Section: Current Status Of Research On Amorphous Formulationsmentioning
confidence: 99%
“…Figure depicts AFM images of the different extrudate products with drug. Extrudates with MA displayed some micropores (Figure A,B) but the submicron structure was very homogeneous in the case of matrix extrusion (Figure A) and slightly less homogeneous for direct extrusion (Figure B) because of the formation of small domains that were only visible at a high magnification . However, there was no clear indication of a phase separation in both formulations containing MA.…”
Section: Resultsmentioning
confidence: 98%